(Q33151393)

English

Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

hypertrophic obstructive cardiomyopathy

0 references

author name string

F H Gietzen

1

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

C J Leuner

2

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

L Obergassel

3

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

C Strunk-Mueller

4

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

H Kuhn

5

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

638-644

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Hypertrophic and restrictive cardiomyopathies in the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

The management of hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Hypertensive hypertrophic cardiomyopathy of the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Natural history of hypertrophic cardiomyopathy in the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Idiopathic Hypertrophic Subaortic Stenosis as Observed in a Large Community Hospital: Relation to Age and History of Hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Hypertrophic cardiomyopathy in the aged

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

21 June 2018

Hypertrophic cardiomyopathy--the benefits of a multidisciplinary approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

31 October 2018

To ablate or operate? that is the question!

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

31 October 2018

Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

31 October 2018

Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

31 October 2018

Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

31 October 2018

Management of symptomatic hypertrophic obstructive cardiomyopathy--long-term results after surgical therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768263

31 October 2018

'The abrupt no-flow': a no-reflow like phenomenon in hypertrophic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiopathic Hypertrophic Subaortic Stenosis in the Elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of clinical features in patients greater than or equal to 60 years of age to those less than or equal to 40 years of age with hypertrophic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New interventions for obstructive hypertrophic cardiomyopathy: promise and prudence

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

1 reference

https://pubmed.ncbi.nlm.nih.gov/15145866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.2003.017509

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33151393&oldid=1537603529"